Phosphorylation of p53 Serine 15 Is a Predictor of Survival for Patients with Hepatocellular Carcinoma

Table 1

Demographics and tumor characteristics of 199 HCC patients.

Variables patients, n	Total cohort (n = 199)
Mean age (years	55 ± 7.99
Gender (Males/Females)	160/39
Patients (HBV/HCV/other)	146/10/43
Median level of serum AFP (ng/ml)	39.6
Cirrhosis (presence/absence)	97/102
Tumor stage (T1/T2/T3	82/84/33
Vascular invasion (yes/no)	116/83
Major portal vein invasion (yes/no)	19/180
Intrahepatic invasion (yes/no)	33/166
Recurrence (yes/no)	120/79

AJCC TNM staging for HCC; T1, solitary tumor without vascular invasion; T2, solitary tumor with vascular invasion or multiple tumors; T3, multiple tumors or tumors involving a major branch of the portal or hepatic vein.
Mean ± standard deviation; T1, T2, and T3 grades were judged using the standard.